SE428800B - Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler - Google Patents

Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler

Info

Publication number
SE428800B
SE428800B SE7612620A SE7612620A SE428800B SE 428800 B SE428800 B SE 428800B SE 7612620 A SE7612620 A SE 7612620A SE 7612620 A SE7612620 A SE 7612620A SE 428800 B SE428800 B SE 428800B
Authority
SE
Sweden
Prior art keywords
subtituated
preparing
procedure
alkyl resorcinols
resorcinols
Prior art date
Application number
SE7612620A
Other languages
English (en)
Swedish (sv)
Other versions
SE7612620L (sv
Inventor
H E Zaugg
C M Lee
R J Michaels
N P Plotnikoff
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SE7612620L publication Critical patent/SE7612620L/xx
Publication of SE428800B publication Critical patent/SE428800B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7612620A 1975-11-14 1976-11-11 Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler SE428800B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/632,126 US4018777A (en) 1975-11-14 1975-11-14 2-Substituted-5-alkyl resorcinols

Publications (2)

Publication Number Publication Date
SE7612620L SE7612620L (sv) 1977-05-15
SE428800B true SE428800B (sv) 1983-07-25

Family

ID=24534181

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612620A SE428800B (sv) 1975-11-14 1976-11-11 Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler

Country Status (18)

Country Link
US (1) US4018777A (el)
JP (1) JPS5262254A (el)
AU (1) AU511431B2 (el)
CA (1) CA1090346A (el)
CH (1) CH618427A5 (el)
DE (1) DE2651708A1 (el)
DK (1) DK506776A (el)
FI (1) FI763241A (el)
FR (2) FR2361887A1 (el)
GB (1) GB1541858A (el)
GR (1) GR61763B (el)
MX (1) MX4120E (el)
NL (1) NL7612607A (el)
NO (1) NO146060C (el)
PH (1) PH12341A (el)
PT (1) PT65816B (el)
SE (1) SE428800B (el)
ZA (1) ZA766571B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US7183313B2 (en) * 2002-08-23 2007-02-27 University Of Connecticut Keto cannabinoids with therapeutic indications
CA2495903A1 (en) * 2002-08-23 2004-03-04 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
US8519134B2 (en) 2009-11-17 2013-08-27 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
MX2019012380A (es) * 2017-05-09 2020-01-23 Eisai R&D Man Co Ltd Cristales de compuesto piranodipiridinico.
EP3935037A4 (en) * 2019-03-08 2023-03-22 The Regents Of The University Of California USE OF 8,9-DIHYDROCANNABIDIOL COMPOUNDS
US20220177666A1 (en) * 2019-03-12 2022-06-09 6th Wave Innovations Corp. Molecularly imprinted polymers for extraction of cannabinoids and uses thereof
EP4251600A2 (en) 2020-11-24 2023-10-04 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cannabinoid derivatives and their use for the treatment of inflammation and/or pain and/or obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans

Also Published As

Publication number Publication date
US4018777A (en) 1977-04-19
PT65816A (en) 1976-12-01
SE7612620L (sv) 1977-05-15
FI763241A (el) 1977-05-15
NO146060B (no) 1982-04-13
PT65816B (en) 1978-05-12
DE2651708A1 (de) 1977-05-18
CH618427A5 (el) 1980-07-31
FR2361887A1 (fr) 1978-03-17
ZA766571B (en) 1977-10-26
CA1090346A (en) 1980-11-25
GB1541858A (en) 1979-03-07
AU2114877A (en) 1978-07-13
JPS5262254A (en) 1977-05-23
FR2361887B1 (el) 1979-03-09
DK506776A (da) 1977-05-15
FR2397385A1 (fr) 1979-02-09
GR61763B (en) 1979-01-09
NL7612607A (nl) 1977-05-17
NO146060C (no) 1982-08-04
FR2397385B1 (el) 1980-04-25
MX4120E (es) 1981-12-15
PH12341A (en) 1979-01-16
NO763881L (el) 1977-05-18
AU511431B2 (en) 1980-08-21

Similar Documents

Publication Publication Date Title
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
NO148703C (no) Fremgangsmaate til fremstilling av polyurea-mikrokapsler
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
IT1058583B (it) Procedimento per preparare idrossibenzaldeidi
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE428800B (sv) Forfarande for framstellning av 2-subtituerade 5-alkylresorcinoler
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
DK324776A (da) Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler
IT1068232B (it) Procedimento per produrre timolo
IT1069076B (it) Procedimento per produrre triclorometil trifluorometilbenzoli
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE7601804L (sv) Forfarande for att framstella agglomererande vanadinsuboxider
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
DK305876A (da) Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid
DK155598C (da) Fremgangsmaade til fremstilling af ethylchlorthioformiat
IT1066655B (it) Procedimento per depurare caprolattame
SE433210B (sv) Forfarande for framstellning av ny cyklohexylfenylderivat
DK143137C (da) Fremgangsmaade til fremstilling af phosphitchlorider
DK143281C (da) Fremgangsmaade til fremstilling af phosphitchlorider
IT1069085B (it) Procedimento per produrre triclorometil-trifluorometil-benzoli